The 47th Annual Samuel D. Plotkin Cardiovascular Symposium
Date & Location:
Tuesday, April 24, 2018
The Log Cabin Banquet & Meeting House, Holyoke, MA
Goal:
The goal of this educational activity is to support safe, effective, patient centered, timely, efficient, equitable and compassionate care.
Topics Include:
- Advances in Oral Anticoagulants
- LVAD Program Update
- Left Ventricular Assistn Device
- A Practical Algorithm for Patient and Device Selection in Acute Cardiogenic Shock
- Left Atrial Appendage Closure
- Type B: Advances, Patient Selection and Case Examples
- Degenerative Mitral Valve Regurgitation and Recent Advances in Percutaneous Repair
Target Audience
This course is designed for cardiologists, hospitalists, primary care physicians, physician assistants, emergency medicine physicians, nurse practitioners, nurses and cardiovascular technologists.
Learning Objectives
- Describe the new oral anticoagulants being used for atrial fibrillation and stroke prevention.
- Discuss a practical approach to management of oral coagulant in patients undergoing elective procedures and PCI.
- Discuss the clinical indications for Left Ventricular Assist Device (LAVD) in patients with advanced heart failure.
- Describe inclusion and exclusion criteria for patients undergoing LVAD.
- List possible complications experienced by patients with LVAD.
- Describe clinical indications, inclusions and exclusions of mechanical assist device in patients with acute cardiogenic shock.
- Discuss different mechanical support options in acute left as well as right ventricular failure.
- Discuss current evidence for left atrial appendage occlusion (LAAO) closure in patients with atrial fibrillation and those at high risk for stroke.
- Discuss a practical approach, current indications, and inclusion/exclusion criteria for device therapy.
- Describe options for treatment in Type B aortic dissection-endovascular vs surgical intervention.
- Discuss physiology, risk factors and management strategies for those at risk for thoracic aortic disection.
- Describe types of mitral valve regurgitation.
- Discuss current literature re: endovascular repair of degenerative mitral regurgitation and for those with high risk for surgical intervention.
Program Schedule
8:00 Registration, Continental Breakfast & Exhibits
8:25 Welcome
Aaron Kugelmass, MD & Ashequl Islam, MD
8:35 Advances in Oral Anticoagulants and a Practical Approach for the Prevention
of CVA in Patients with Atrial Fibrillation and PCI
Christopher P. Cannon, MD
9:20 Questions & Answers
Moderator: Heba Wassif, MD
9:25 LVAD Program Update
David Deaton, MD
9:30 Left Ventricular Assist Device: Patient Screening, Selection, Case Example
and Literature
Hari Mallidi, MD
10:15 Questions & Answers
Moderator: David Deaton, MD
10:20 Refreshment Break & Exhibits
10:40 SHOCK Program Update
10:45 A Practical Algorithm for Patient and Device Selection in Acute Cardiogenic
Shock
Ajay Srivastrava, MD
11:25 Questions & Answers
Moderator: Jamie Hernandez-Montfort, MD
11:30 Lunch
12:35 Left Atrial Appendage Closure: Patient Screening Selection, Case Example
and Literature Review
Jacob Koruth, MD
1:20 Questions & Answers
Moderator: Fadi Chalhoub, MD
1:25 Refreshment Break & Exhibits
1:40 Type B: Advances, Patient Selection and Case Examples
Neal Hadro, MD & Marc Norris, MD
2:25 Questions & Answers
Moderator: Dan Engelman, MD
2:30 Degenerative Mitral Valve Regurgitation and Recent Advances in Percutaneous
Repair
William Hiser, MD & Ashequl Islam, MD
3:15 Adjourn
Christopher Cannon, MD
Senior Physician, Brigham and Women's Hospital
Professor of Medicine, Harvard Medical School
Executive Director,
Cardiometabolic Trials, Balm Institute for Clinical Research
Dr. Cannon is a consultant for Alnylam, Amgen, Amarin, Arisaph, Astra Zeneca, BI, BMD, Eisai,
GlaxoSmithKline, Kowa, Lipimedix, Merck, Pfizer, Regeneron, Sanofi, Tekeda and receives grants from Amgen, Arisaph, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Janssen, Merck & Takeda.
Fadi Chalhoub, MD*
Clinical Cardiac Electrophysiologist
Baystate Medical Center
David Deaton, MD*
Assisstant Professor of Surgery
Tufts University School of Medicine
Baystate Cardiac Surgery
Baystate Medical Center
Daniel Engelman, MD
Associate Professor
University of Massachusetts Medical School-Baystate
Interim Chief, Baystate Cardiac Surgery
Baystate Medical Center
Dr. Engelman is a consultant for Astate Medical, Astellas Pharmaceuticals & Edward Lifesciences.
Neal Hadro, MD*
Assistant Professor of Surgery
University of Massachusetts Medical School - Baystate
Chief of Vascular Services
Baystate Medical Center
Jamie Hernandez-Montfort, MD
Assistant Professor of Medicine
University of Massachusetts Medical School-Baystate
Co-Director of Cardiogenic Shock and AMCS Program
Baystate Medical Center
Dr. Hernandez-Montfort is a consultant and receives grant/research support from Abiomed.
William Hiser, MD, FACC*
Interim Regional Medical Director, Non-Invasive Cardiology
Baystate Heart and Vascular Proram
Jacob Koruth, MD
Assistant Professor of Medicine
Division of Cardiology
The Mount Sinai Hospital, New York
Aaron Kugelmass, MD*
Tufts University School of Medicine
Chief, Division of Cardiology
VP, Medical Director, Heart & Vascular Center
Baystate Medical Center
Ashequl Islam, MD, MPH
Associate Clinical Professor
Tufts University School of Medicine
Director of VHD Program and Heart and Vascular Dev and Growth
Baystate Medical Center
Dr. Islam is a consultant for Edwards Life Sciences and Medtronic.
Evan Lau, MD*
Assistant Professor of Medicine
Universithy of Massachusetts Medical School - Baystate
Interventional Cardiologist
Co-Director of Cardiogenic Shock and AMCS Program
Baystate Medical Center
Hari Mallidi, MD*
Associate Professor
Division of Thoracic & Cardiac Surgery
Brigham and Women's Hospital
Marc Norris, MD*
Assistant Professor of Surgery
Tufts University School of Medicine
Baystate Vascular Services
Baystate Medical Center
Ajay Srivastava, MD*
Advanced Heart Failure Cardiologist
Scripps Health
Dr. Srivastava is a consultant for Abbott and Abiomed
Heba Wassif, MD, MPH, FACC*
Non-Invasive Cardiology
Baystate Medical Center
Faculty Disclosure
The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Faculty or planner conflicts of interest are resolved before the educational activity.
Faculty and planners marked with an * have no commercial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
In support of improving patient care, Baystate Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Available Credit
- 5.00 AMA PRA Category 1 Credit™
- 5.00 ANCC Contact Hours
- 5.00 BCIPE Instructional Hours
Price
Early Online Rate | |
. Use Code: Car60 This code expires 14 days before the event. | |
|
This course opens for enrollment on: | Thu, 03/22/2018 - 12:00am |
In order to receive credit, the evaluation must be completed by: | Thu, 12/31/2020 - 12:00am |
We appreciate your business and sincerely wish to meet your educational needs. We understand that the schedule of a busy professional, like yourself, is subject to change. Therefore, we have included information about our refund/cancellation policies for your convenience below.
Cancellation:
If you must cancel, telephone Baystate Continuing Interprofessional Education at 413-322-4242 and follow your call with a written/email request. All cancellations will incur a $25.00 fee. Please note that we cannot refund cancellations received less than two weeks (10 business days) before the program date.
Refund Policy:
Your refund, less a cancellation fee, will be processed within two (2) weeks from the date we receive the written notification. For credit card refunds, please allow one to two (1-2) billing cycles for the credit to appear on your statement.
Specific Aids or Services:
Please call Baystate Continuing Interprofessional Education at 413-322-4242 if, under the Americans with Disabilities Act, you require specific aids or services during your visit to this continuing education program.